Skip directly to local search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home
Share
Compartir

What's New with VISs

This page offers the latest information about vaccine information statements currently under development or newly released.


March 5, 2014

Multi-Vaccine Vaccine Information Statement

The Multi-Vaccine Vaccine Information Statement is being temporarily removed from circulation while it is being updated. In the meantime, please use the individual VISs when vaccinating children with DTaP, Hib, Hepatitis B, PCV13, Polio, and Rotavirus vaccines. We hope to have an updated edition available by mid-2014.

February 4, 2014

Updated VISs for Td and Hib

Updated VISs for Td and Hib are now available. The Td VIS replaces the older Td/Tdap VIS, which had been pressed into temporarily service for Td alone; and the new Hib edition allows us to finally retire the elder statesman of VISs (Hib was last published in 1998). Because both VISs contain a change in the adverse events section (“problems that can happen after any vaccine”), it is advisable to begin using the updated VISs immediately.

Provider Guidelines for both vaccines will be available soon.

January 24, 2014

Updated Japanese encephalitis VIS.

Updated VIS for Japanese Encephalitis is available. The major change from the previous edition concerns the reduction in the minimum approved age from 17 years to 2 months. There are also changes in the "risks" section. An accompanying "Provider Information" document will be available soon.

September 26, 2013

New Provider Information for Influenza VISs

A new "Influenza Provider Information" document, which supplements the 2013-14 influenza VISs, is available. These provider guidelines supplement the VIS and summarize relevant ACIP recommendations; include more detailed information about indications, schedules, and precautions; and contain other information giving providers a quick reference to help address common patients' questions.

September 19, 2013

Updated Rotavirus VIS

The most significant change in the August 26, 2013 updated rotavirus VIS is in the estimated rates of intussusception following vaccination. Because this change concerns a potential adverse event, the new VIS should be used beginning immediately. The accompanying Provider Information Sheet gives more detailed information for discussing the vaccine with parents. When using the multi-vaccine VIS for patients receiving rotavirus vaccine, give the new rotavirus VIS in addition to the multi-VIS. The multi-VIs is being updated to reflect these changes.

August 7, 2013

Small Change to Inactivated Influenza VIS

A change has been made to Section 3 of the Inactivated Influenza vaccine VIS, to the bullet regarding allergies, noting the availability of an egg-free formulation. The original language was not incorrect, and providers who have already printed copies of that VIS do NOT need to discard them. The edition date of the VIS (July 26, 2013) has not changed. Providers should make severely egg-allergic patients aware that an egg-free influenza vaccine is available.

July 26, 2013

2013-14 Influenza VISs

The 2013-14 influenza VISs have been posted, and are dated July 26, 2013. There are separate VISs for the inactivated and the live, attenuated intranasal vaccines. The “inactivated” vaccine influenza VIS may be used for all non-live virus formulations (e.g., trivalent, quadrivalent, cell-culture, recombinant, intradermal, high-dose). Provider Guidelines for influenza vaccine VISs will be available soon.

June 18, 2013

Barcodes Are Now On All VISs

2D barcodes, which can be used to scan the VIS name and edition date into an electronic medical record, have been added to all VISs. VISs printed before these barcodes were added may still be used. See Barcodes on Vaccine Information Statements for more information.

VISs to Receive a New Look

Soon, all VISs will be re-released in a slightly modified format. They will have a consistent look, and consistent language for the sections common to all VISs. These will not be new VISs, but redesigned versions of existing VISs, with the same edition dates. Existing stocks needn’t be discarded.


May 17, 2013

Minor Update to Gardasil VIS

The pregnancy registry for Gardasil has been terminated by the manufacturer. Consequently, the reference to the registry has been removed from Section 4 of the Gardasil VIS. This is the only change. Stocks of the previous VIS may still be used as long as patients are made aware that the registry no longer exists. The updated Gardasil VIS has an edition date of 5/17/13.


May 9, 2013

Tdap/TD

A new VIS for Tdap, incorporating updated recommendations for pregnant women, is now available. The existing Td/Tdap VIS should continue to be used for patients receiving Td, until an updated Td VIS is available.


April 11, 2013

Hib

Work on an updated Hib VIS is also beginning. It will probably contain information about MenHibrix, regardless of whether a separate MenHibrix VIS is developed.

Meningococcal

Work is beginning on a new meningococcal VIS, to incorporate recommendations from the recently published ACIP statement. We expect it will take at least several months to accomplish the necessary reviews and clearance. Discussions are ongoing regarding whether a separate VIS for MenHibrix will be produced.

Rotavirus

An updated rotavirus VIS is temporarily on hold while some new safety data are being reviewed.

Yellow Fever

An updated YF VIS should be out of clearance after several minor comments from subject-matter experts are addressed.

March 1, 2013

PCV13

CDC released an updated Pneumococcal Conjugate (PCV13) VIS with an edition date of 2/27/13. The update primarily added information for adults receiving the vaccine. (3/1/13)

February 27, 2013

Provider Information

Beginning in 2013, each new or updated VIS will be accompanied with a "Provider Information" document, which will

  • Summarize relevant ACIP recommendations
  • Include more detailed information about indications, schedules, and precautions
  • Contain other information that gives providers a quick reference to help address common patients' questions. An example of this is the Provider Information: PCV13 VIS.

Top of Page

 

Images and logos on this website which are trademarked/copyrighted or used with permission of the trademark/copyright or logo holder are not in the public domain. These images and logos have been licensed for or used with permission in the materials provided on this website. The materials in the form presented on this website may be used without seeking further permission. Any other use of trademarked/copyrighted images or logos requires permission from the trademark/copyright holder...more

External Web Site Policy This graphic notice means that you are leaving an HHS Web site. For more information, please see the Exit Notification and Disclaimer policy.

 

Contact Us:
  • Centers for Disease Control and Prevention
    1600 Clifton Rd
    Atlanta, GA 30333
  • 800-CDC-INFO
    (800-232-4636)
    TTY: (888) 232-6348
    Contact CDC-INFO
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO
A-Z Index
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  27. #